Clostridial toxin derivatives able to modify peripheral sensory afferent functions
US6962703B2 · kind B2 · utility
54Cited by
3References
29Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 20, 2002 |
| Grant date | Nov 8, 2005 |
| Priority date | — |
| Expiry date | Jan 20, 2023 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/832
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to an agent specific for peripheral sensory afferents. The agent may inhibit the transmission of signals between a primary sensory afferent and a projection neutron by controlling the release of at least one neurotransmitter or neuromodulator from the primary sensory afferent. The agent may be used in or as a pharmaceutical for the treatment of pain, particularly chronic pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.